ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $424 | -4.5% | 20,348 | +9.8% | 0.05% | -43.2% |
| Q2 2023 | $444 | +37.5% | 18,535 | +8.1% | 0.08% | +84.1% |
| Q1 2023 | $323 | -25.7% | 17,142 | -37.2% | 0.04% | -33.3% |
| Q4 2022 | $435 | -99.9% | 27,316 | +48.4% | 0.07% | +43.5% |
| Q3 2022 | $301,000 | -14.0% | 18,401 | -25.9% | 0.05% | -25.8% |
| Q2 2022 | $350,000 | -15.3% | 24,834 | +45.5% | 0.06% | -8.8% |
| Q1 2022 | $413,000 | -15.9% | 17,072 | -18.9% | 0.07% | -19.0% |
| Q4 2021 | $491,000 | +3.6% | 21,048 | -26.3% | 0.08% | +47.4% |
| Q3 2021 | $474,000 | -17.0% | 28,553 | +21.9% | 0.06% | -13.6% |
| Q2 2021 | $571,000 | -16.4% | 23,417 | -11.5% | 0.07% | -45.5% |
| Q1 2021 | $683,000 | -49.9% | 26,456 | +3.9% | 0.12% | -26.7% |
| Q4 2020 | $1,362,000 | – | 25,468 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |